STOCK TITAN

PTCT (NASDAQ: PTCT) insider files Form 144 for planned share sale

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Form 144 discloses a planned sale of 3,376 common shares of the issuer’s stock through Fidelity Brokerage Services LLC on NASDAQ, with an approximate sale date of 01/07/2026. The shares have an indicated aggregate market value of $261,381.58, and the issuer has 80,288,305 common shares outstanding.

The shares to be sold were acquired on 01/07/2026 via an option granted on 01/07/2022, with the purchase price paid in cash. Over the prior three months, the seller, Mark Boulding, reported additional sales of common shares: 3,375 shares for $214,094.81 on 10/07/2025, 2,812 shares for $213,690.35 on 11/17/2025, 2,266 shares for $171,190.18 on 01/05/2026, and 1,739 shares for $133,811.88 on 01/06/2026.

Positive

  • None.

Negative

  • None.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What share sale does this PTCT Form 144 notice cover?

The notice covers a proposed sale of 3,376 shares of common stock of the issuer, to be sold through Fidelity Brokerage Services LLC on NASDAQ around 01/07/2026.

What is the market value of the PTCT shares to be sold under this Form 144?

The 3,376 common shares reported for sale have an aggregate market value of $261,381.58 according to the Form 144 disclosure.

How and when were the PTCT shares in this Form 144 acquired?

The common shares were acquired on 01/07/2026 through an option granted on 01/07/2022, with the purchase price paid in cash on the acquisition date.

How many PTCT shares are outstanding according to this Form 144?

The filing states that there are 80,288,305 common shares outstanding for the issuer.

Who is selling PTCT shares and what were recent prior sales?

The seller is Mark Boulding. In the past three months, he reported sales of 3,375 shares for $214,094.81 on 10/07/2025, 2,812 shares for $213,690.35 on 11/17/2025, 2,266 shares for $171,190.18 on 01/05/2026, and 1,739 shares for $133,811.88 on 01/06/2026.

Which broker is handling the PTCT Form 144 sale and on what exchange?

The planned sale will be handled by Fidelity Brokerage Services LLC, with the common shares to be sold on the NASDAQ exchange.
Ptc Therapeutics

NASDAQ:PTCT

PTCT Rankings

PTCT Latest News

PTCT Latest SEC Filings

PTCT Stock Data

5.67B
78.09M
Biotechnology
Pharmaceutical Preparations
Link
United States
WARREN